Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients
about
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosisMicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole bloodIs It worth Considering Circulating microRNAs in Multiple Sclerosis?MicroRNAs in autoimmune diseasesThe genetics of multiple sclerosis: review of current and emerging candidatesmiRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencingMicroRNA regulation of lymphocyte tolerance and autoimmunityMicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and developmentTreg functional stability and its responsiveness to the microenvironmentMicroRNAs, Major Players in B Cells Homeostasis and FunctionMicroRNAs as biomarkers for CNS diseaseThe miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and diseaseCirculating microRNAs as biomarkers for disease staging in multiple sclerosismiR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammationUnraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis.Expression, regulation and function of microRNAs in multiple sclerosisPathophysiology of translational regulation by microRNAs in multiple sclerosis.Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity.MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases.Circulating microRNAs involved in multiple sclerosis.miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases.MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a.Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureGenetic association and altered gene expression of mir-155 in multiple sclerosis patients.Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity.Immunopathologic processes in sympathetic ophthalmia as signified by microRNA profilingFunctional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation.MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease.miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.MicroRNA dysregulation in multiple sclerosis.Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.Next-generation sequencing identifies microRNAs that associate with pathogenic autoimmune neuroinflammation in ratsNatalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.MicroRNAs: The Role in Autoimmune InflammationEpigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatmentMicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor
P2860
Q21135220-B51C719C-EF87-4F33-B6A0-0E010B9EEF34Q21562182-384CD48A-4011-4996-B515-CB09AC7E96DCQ26752505-4CFD5A41-6047-4DA1-92BF-DC64C4ADA334Q26824814-23A72A07-C22A-4FD0-99BB-EE9D2483B9E5Q26825782-1C9F553F-826E-4FA8-A203-C77241835E71Q26852074-0D7CB9F5-8B57-4B6C-B6E8-6100D02448FCQ26852975-8B60F2BD-959C-4A69-82F0-D461DEFC8BFAQ27003271-2BE3EEF5-2ABC-4ABD-9570-E04566E635F2Q27008946-D350585D-936F-42D6-985A-90C8BCED9FA0Q27010231-8FA62EE0-E214-4D6C-BF31-01742F409228Q27013998-167F4883-79B6-439F-80BE-8C7C6C4E0E71Q27015587-150884BF-CB14-4447-A522-584D41AC9FE7Q28287246-672C02AD-AD5A-4BEA-9F8E-93CD4C250664Q33556109-84826D59-6383-4A86-9FF3-2823C40F322AQ33678267-422DD03F-86BF-4DD1-AE1E-C1198BB810F4Q33754662-2F9929F5-AC8A-4088-8AB4-7DEB5DB4ED0AQ34174676-93F957C6-2A31-46B3-9A83-9F9F5C6D9C26Q34233085-E6584D5F-AA27-440A-8340-3CCD502E74F6Q34244568-2CFB086E-0C9B-4DC1-AA76-A1140208A418Q34246016-1F1276C9-34BC-48F3-951D-B77EBCFB71D5Q34354883-684E83A3-A707-4DBD-8E4A-70ABE6D61540Q34772318-F70E48F1-A17A-4B02-B481-CAE418A36009Q34878368-8B53D6D1-4EDD-459B-8CDF-D974DF5FF06DQ34980198-360BFD5E-30C7-4358-9C46-E3F72CE1CE20Q34994463-610F977D-0AFE-4075-BC9E-17C674ECEBC5Q35078327-2F03083D-5825-47D4-A891-1076F726DFA3Q35669464-0CC33586-834F-4547-96A5-ABF51AB025CCQ35828632-4B9546E8-B118-429D-8B24-4B9559F74086Q35930798-CADAFF01-65E6-442E-AD68-A0665BDA7381Q36082773-412FF08D-53C4-44CD-BB0C-1482489F3EE5Q36101314-27AC04AF-2786-4CF6-84BF-117B456C03F2Q36127627-6755E68C-92FB-4175-BC49-1FF797F458E1Q36139956-A95D5EEB-B167-4CAF-B771-B64BABB7FF75Q36551019-BE085896-537D-4681-B53C-702F0E9D6D21Q36655150-E3D6AFB7-A702-4003-B771-95A2691795D9Q36748227-8D2AF75B-EBEC-4131-B142-20A074CA5802Q36767522-0B7A14D7-15D4-4CBE-A1FB-D2F3C1155412Q36815415-813A3F59-51CE-487B-B807-0750A4BE42EBQ36948933-2FF6E8B3-9B1F-4800-B2E5-17F498ACEE9DQ37117838-2DF11F84-D8A6-4BA5-B579-1826B751FA0C
P2860
Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@ast
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@en
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@nl
type
label
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@ast
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@en
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@nl
prefLabel
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@ast
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@en
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@nl
P2093
P2860
P921
P3181
P356
P1476
Altered expression of miR-17-5 ...... ng multiple sclerosis patients
@en
P2093
Francine Hoffmann
Jens Kuhle
Raija L P Lindberg
P2860
P304
P3181
P356
10.1002/EJI.200940032
P407
P577
2010-03-01T00:00:00Z